Verizon (VZ) EVP Kyle Malady Receives Phantom Stock Award

What Happened
Kyle Malady, EVP and Group CEO — VZ Business, was granted 123.236 shares of phantom stock on 2026-08-27. The filing reports an acquisition value of $14.11 per phantom share, for a total reported value of $1,739. This was an award/grant (derivative cash-settled phantom stock), not an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-08-27; 123.236 phantom shares @ $14.11 each (total $1,739).
• Transaction type: Award/Grant of phantom stock (code A, derivative — cash-settled).
• Shares owned after transaction: Not specified in the filing.
• Footnotes:
  • F1: Each phantom share is the economic equivalent of a portion of one common share and is settled in cash; payable upon events the reporting person selects under the deferred compensation plan.
  • F2: Includes phantom stock acquired through dividend reinvestment.
• Filing timeliness: Form filed 2026-08-31 (four days after the transaction); this appears later than the typical two-business-day Form 4 deadline.

Context
Phantom stock is a deferred-compensation award that tracks stock value but is paid in cash when vested or when payout events occur; it does not transfer actual shares to the insider. Awards like this are routine executive compensation and do not by themselves indicate a buy or sell signal in the market.